Parkman Healthcare Partners LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
Parkman Healthcare Partners LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$7,969,216
-18.7%
88,962
-22.7%
1.46%
-14.0%
Q2 2023$9,796,294
-15.9%
115,061
-18.2%
1.70%
-33.0%
Q1 2023$11,646,235
+11.9%
140,740
+6.3%
2.53%
-8.6%
Q4 2022$10,411,530
+21.5%
132,378
+14.3%
2.77%
+13.7%
Q3 2022$8,572,000
+425.9%
115,797
+363.2%
2.44%
+306.2%
Q2 2022$1,630,000
-16.1%
25,000
+42.9%
0.60%
+33.0%
Q1 2021$1,943,000
-28.0%
17,500
-42.0%
0.45%
-40.7%
Q2 2020$2,700,000
+78.8%
30,147
+99.0%
0.76%
+8.7%
Q1 2020$1,510,000
-78.2%
15,147
-74.9%
0.70%
-65.0%
Q4 2019$6,923,00060,2502.00%
Other shareholders
HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders